Literature DB >> 11050174

Endogenously expressed estrogen receptor and coactivator AIB1 interact in MCF-7 human breast cancer cells.

M K Tikkanen1, D J Carter, A M Harris, H M Le, D O Azorsa, P S Meltzer, F E Murdoch.   

Abstract

Coactivators are believed to mediate estrogen-induced gene responses via interaction with estrogen receptors (ER). Currently, a major challenge is to determine the importance of each coactivator in a specific cell type and promoter context in response to a particular ligand. The potential of ER to interact with a growing list of coactivators has been shown in a variety of in vitro and gene transfer assays, yet very few data have demonstrated the interaction of endogenous coactivators with ER in intact cells. We report here a ligand-specific interaction of endogenous human ER (hER) and the AIB1 coactivator in MCF-7 human breast cancer cells by using immunoprecipitation analyses. Complexes between endogenously expressed hER and AIB1 were detected in estradiol-treated cells and to a much lesser extent in cells treated with the partial agonist, monohydroxytamoxifen. We were unable to detect an hER-SRC-1 complex in our immunoprecipitations from MCF-7 cells. The in vitro-binding affinity for mouse ER interaction with AIB1 was estimated to be 40-120 nM. We conclude that AIB1 is a major coactivator for hER in MCF-7 human breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11050174      PMCID: PMC18799          DOI: 10.1073/pnas.220427297

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

Review 1.  The role of coactivators in steroid hormone action.

Authors:  C Bevan; M Parker
Journal:  Exp Cell Res       Date:  1999-12-15       Impact factor: 3.905

Review 2.  ICI 182,780, a new antioestrogen with clinical potential.

Authors:  A E Wakeling; J Bowler
Journal:  J Steroid Biochem Mol Biol       Date:  1992-09       Impact factor: 4.292

3.  AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer.

Authors:  S L Anzick; J Kononen; R L Walker; D O Azorsa; M M Tanner; X Y Guan; G Sauter; O P Kallioniemi; J M Trent; P S Meltzer
Journal:  Science       Date:  1997-08-15       Impact factor: 47.728

4.  The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development.

Authors:  J Xu; L Liao; G Ning; H Yoshida-Komiya; C Deng; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 5.  Selective estrogen receptor modulators (SERMs): A first step in the development of perfect hormone replacement therapy regimen.

Authors:  D P McDonnell
Journal:  J Soc Gynecol Investig       Date:  2000 Jan-Feb

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 7.  Remodeling the estrogen receptor model.

Authors:  J Gorski; W Welshons; D Sakai
Journal:  Mol Cell Endocrinol       Date:  1984-06       Impact factor: 4.102

Review 8.  The SRC family of nuclear receptor coactivators.

Authors:  C Leo; J D Chen
Journal:  Gene       Date:  2000-03-07       Impact factor: 3.688

9.  Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation.

Authors:  E T Alarid; N Bakopoulos; N Solodin
Journal:  Mol Endocrinol       Date:  1999-09

10.  In vivo insulin mimetic effects of pV compounds: role for tissue targeting in determining potency.

Authors:  A P Bevan; J W Burgess; J F Yale; P G Drake; D Lachance; G Baquiran; A Shaver; B I Posner
Journal:  Am J Physiol       Date:  1995-01
View more
  10 in total

1.  Differential recruitment of co-regulatory proteins to the human estrogen receptor 1 in response to xenoestrogens.

Authors:  L Cody Smith; Jessica C Clark; Joseph H Bisesi; P Lee Ferguson; Tara Sabo-Attwood
Journal:  Comp Biochem Physiol Part D Genomics Proteomics       Date:  2016-04-20       Impact factor: 2.674

2.  Altered AIB1 or AIB1Δ3 expression impacts ERα effects on mammary gland stromal and epithelial content.

Authors:  Rebecca E Nakles; Maddalena Tilli Shiffert; Edgar S Díaz-Cruz; M Carla Cabrera; Maram Alotaiby; Anne M Miermont; Anna T Riegel; Priscilla A Furth
Journal:  Mol Endocrinol       Date:  2011-02-03

Review 3.  Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors.

Authors:  Jin-Qiang Chen; Terry R Brown; Jose Russo
Journal:  Biochim Biophys Acta       Date:  2009-04-05

4.  Characterization of transcriptional regulatory domains of ankyrin repeat cofactor-1.

Authors:  Aihua Zhang; Chia-Wei Li; J Don Chen
Journal:  Biochem Biophys Res Commun       Date:  2007-05-11       Impact factor: 3.575

Review 5.  SRC-3, a Steroid Receptor Coactivator: Implication in Cancer.

Authors:  Licen Li; Chu-Xia Deng; Qiang Chen
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

6.  Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer.

Authors:  V J Gnanapragasam; H Y Leung; A S Pulimood; D E Neal; C N Robson
Journal:  Br J Cancer       Date:  2001-12-14       Impact factor: 7.640

7.  AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.

Authors:  Francesca De Amicis; Chiara Chiodo; Catia Morelli; Ivan Casaburi; Stefania Marsico; Rosalinda Bruno; Diego Sisci; Sebastiano Andò; Marilena Lanzino
Journal:  BMC Cancer       Date:  2019-11-04       Impact factor: 4.430

8.  Development of a novel molecular sensor for imaging estrogen receptor-coactivator protein-protein interactions.

Authors:  Madryn C Lake; Quang-Dé Nguyen; Simak Ali; Eric O Aboagye
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

9.  IDP-denovo: de novo transcriptome assembly and isoform annotation by hybrid sequencing.

Authors:  Shuhua Fu; Yingke Ma; Hui Yao; Zhichao Xu; Shilin Chen; Jingyuan Song; Kin Fai Au
Journal:  Bioinformatics       Date:  2018-07-01       Impact factor: 6.937

10.  Point-activated ESR1Y541S has a dramatic effect on the development of sexually dimorphic organs.

Authors:  Alexandra M Simond; Chen Ling; Michaela J Moore; Stephanie A Condotta; Martin J Richer; William J Muller
Journal:  Genes Dev       Date:  2020-09-10       Impact factor: 11.361

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.